Literature DB >> 22949516

Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of Plasmodium vivax: local and global patterns.

Rosa del Carmen Miluska Vargas-Rodríguez1, Melissa da Silva Bastos, Maria José Menezes, Pamela Orjuela-Sánchez, Marcelo U Ferreira.   

Abstract

Emerging resistance to chloroquine (CQ) poses a major challenge for Plasmodium vivax malaria control, and nucleotide substitutions and copy number variation in the P. vivax multidrug resistance 1 (pvmdr-1) locus, which encodes a digestive vacuole membrane transporter, may modulate this phenotype. We describe patterns of genetic variation in pvmdr-1 alleles from Acre and Amazonas in northwestern Brazil, and compare then with those reported in other malaria-endemic regions. The pvmdr-1 mutation Y976F, which is associated with CQ resistance in Southeast Asia and Oceania, remains rare in northwestern Brazil (1.8%) and its prevalence mirrors that of CQ resistance worldwide. Gene amplification of pvmdr-1, which is associated with mefloquine resistance but increased susceptibility to CQ, remains relatively rare in northwestern Brazil (0.9%) and globally (< 4%), but became common (> 10%) in Tak Province, Thailand, possibly because of drug-mediated selection. The global database we have assembled provides a baseline for further studies of genetic variation in pvmdr-1 and drug resistance in P. vivax malaria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949516      PMCID: PMC3516255          DOI: 10.4269/ajtmh.2012.12-0094

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains.

Authors:  Juliana Martha Sá; Takashi Nomura; Joana d'Arc Neves; J Kevin Baird; Thomas E Wellems; Hernando A del Portillo
Journal:  Exp Parasitol       Date:  2005-04       Impact factor: 2.011

Review 2.  Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.

Authors:  J K Baird; B Leksana; S Masbar; D J Fryauff; M A Sutanihardja; F S Wignall; S L Hoffman
Journal:  Am J Trop Med Hyg       Date:  1997-06       Impact factor: 2.345

3.  Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries.

Authors:  Feng Lu; Chae Seung Lim; Deok-Hwa Nam; Kwonkee Kim; Khin Lin; Tong-Soo Kim; Hyeong-Woo Lee; Jun-Hu Chen; Yue Wang; Jetsumon Sattabongkot; Eun-Taek Han
Journal:  Acta Trop       Date:  2010-10-08       Impact factor: 3.112

4.  Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity.

Authors:  Sara Brega; Benoit Meslin; Frédérique de Monbrison; Carlo Severini; Luigi Gradoni; Rachanee Udomsangpetch; Inge Sutanto; François Peyron; Stéphane Picot
Journal:  J Infect Dis       Date:  2004-12-09       Impact factor: 5.226

Review 5.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

6.  Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.

Authors:  Ric N Price; Anne-Catrin Uhlemann; Alan Brockman; Rose McGready; Elizabeth Ashley; Lucy Phaipun; Rina Patel; Kenneth Laing; Sornchai Looareesuwan; Nicholas J White; François Nosten; Sanjeev Krishna
Journal:  Lancet       Date:  2004 Jul 31-Aug 6       Impact factor: 79.321

7.  Determinants of in vitro drug susceptibility testing of Plasmodium vivax.

Authors:  B Russell; F Chalfein; B Prasetyorini; E Kenangalem; K Piera; R Suwanarusk; A Brockman; P Prayoga; P Sugiarto; Q Cheng; E Tjitra; N M Anstey; R N Price
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

8.  Chloroquine-resistant Plasmodium vivax, Brazilian Amazon.

Authors:  Franklin Simoes de Santana Filho; Ana Ruth de Lima Arcanjo; Yonne Melo Chehuan; Monica Regina Costa; Flor Ernestina Martinez-Espinosa; Jose Luis Vieira; Maria das Graças Vale Barbosa; Wilson Duarte Alecrim; Maria das Graças Costa Alecrim
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

9.  World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

Authors:  Christopher V Plowe; Cally Roper; John W Barnwell; Christian T Happi; Hema H Joshi; Wilfred Mbacham; Steven R Meshnick; Kefas Mugittu; Inbarani Naidoo; Ric N Price; Robert W Shafer; Carol H Sibley; Colin J Sutherland; Peter A Zimmerman; Philip J Rosenthal
Journal:  Malar J       Date:  2007-09-06       Impact factor: 2.979

10.  Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.

Authors:  Rossarin Suwanarusk; Bruce Russell; Marina Chavchich; Ferryanto Chalfein; Enny Kenangalem; Varakorn Kosaisavee; Budi Prasetyorini; Kim A Piera; Marion Barends; Alan Brockman; Usa Lek-Uthai; Nicholas M Anstey; Emiliana Tjitra; François Nosten; Qin Cheng; Ric N Price
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

View more
  25 in total

1.  Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms.

Authors:  Jessica T Lin; Jaymin C Patel; Oksana Kharabora; Jetsumon Sattabongkot; Sinuon Muth; Ratawan Ubalee; Anthony L Schuster; William O Rogers; Chansuda Wongsrichanalai; Jonathan J Juliano
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

2.  Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia.

Authors:  Lemu Golassa; Berhanu Erko; Frederick N Baliraine; Abraham Aseffa; Göte Swedberg
Journal:  Malar J       Date:  2015-04-16       Impact factor: 2.979

Review 3.  Emerging Plasmodium vivax resistance to chloroquine in South America: an overview.

Authors:  Lígia Antunes Gonçalves; Pedro Cravo; Marcelo Urbano Ferreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08       Impact factor: 2.743

4.  Effects of mefloquine use on Plasmodium vivax multidrug resistance.

Authors:  Nimol Khim; Voahangy Andrianaranjaka; Jean Popovici; Saorin Kim; Arsene Ratsimbasoa; Christophe Benedet; Celine Barnadas; Remy Durand; Marc Thellier; Eric Legrand; Lise Musset; Michela Menegon; Carlo Severini; Bakri Y M Nour; Magali Tichit; Christiane Bouchier; Odile Mercereau-Puijalon; Didier Ménard
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

5.  Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011.

Authors:  Constanza Martinez-Valdebenito; Mario Calvo; Cecilia Vial; Rita Mansilla; Claudia Marco; R Eduardo Palma; Pablo A Vial; Francisca Valdivieso; Gregory Mertz; Marcela Ferrés
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

6.  Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon.

Authors:  Gisely C Melo; Wuelton M Monteiro; André M Siqueira; Siuhelem R Silva; Belisa M L Magalhães; Aline C C Alencar; Andrea Kuehn; Hernando A del Portillo; Carmen Fernandez-Becerra; Marcus V G Lacerda
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

7.  Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnel.

Authors:  Dong-Il Chung; Sookwan Jeong; Sylvatrie-Danne Dinzouna-Boutamba; Hye-Won Yang; Sang-Geon Yeo; Yeonchul Hong; Youn-Kyoung Goo
Journal:  Malar J       Date:  2015-09-04       Impact factor: 2.979

8.  Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.

Authors:  Chanthap Lon; Jessica E Manning; Pattaraporn Vanachayangkul; Mary So; Darapiseth Sea; Youry Se; Panita Gosi; Charlotte Lanteri; Suwanna Chaorattanakawee; Sabaithip Sriwichai; Soklyda Chann; Worachet Kuntawunginn; Nillawan Buathong; Samon Nou; Douglas S Walsh; Stuart D Tyner; Jonathan J Juliano; Jessica Lin; Michele Spring; Delia Bethell; Jaranit Kaewkungwal; Douglas Tang; Char Meng Chuor; Prom Satharath; David Saunders
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 9.  N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine.

Authors:  Fernanda G Versiani; Maria E Almeida; Luis A Mariuba; Patricia P Orlandi; Paulo A Nogueira
Journal:  Clin Dev Immunol       Date:  2013-09-28

10.  High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.

Authors:  Fernanda G Versiani; Maria E M Almeida; Gisely C Melo; Francivaldo O L Versiani; Patrícia P Orlandi; Luís André M Mariúba; Leidiane A Soares; Luciana P Souza; Antonio A da Silva Balieiro; Wuelton M Monteiro; Fabio T M Costa; Hernando A del Portillo; Marcus V G Lacerda; Paulo A Nogueira
Journal:  Malar J       Date:  2013-08-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.